SERMs, such as the breast cancer drug tamoxifen and the osteoporosis drug raloxifene, have estrogen-like effects in some tissues but either no effects or antiestrogenic effects in other tissues in which estrogen receptors are present [19]. The gene discussed is ESR1; the disease is breast carcinoma.